Reynaud M, Gaudin-Colombel A F
Service de Psychiatrie B, CHU de Clermont-Ferrand, 63003 Clermont-Ferrand cedex, France.
Alcohol Alcohol. 2001 Jan-Feb;36(1):89-95. doi: 10.1093/alcalc/36.1.89.
The health costs of alcohol-related problems in France were estimated using two cost evaluation approaches: (1) estimate based on the proportion of cases attributable to alcohol abuse (the alcohol abuse factor); (2) estimate based on prevalence of alcohol abuse for in- and out-patients. For a 10% prevalence of alcohol abuse in the general population, the minimum cost in 1996 was about US$ 2300 million; for a prevalence of 15% it was US$ 2700 million. This cost concerns the health disorders that are linked directly or indirectly to alcohol abuse. It did not allow for injuries from accidents caused by alcohol intoxication and undervalued the cost of out-patient care. Based on the prevalence of alcohol-related disorders seen at hospitals, a percentage of the total in-patient and out-patient costs due to effects of alcohol could be estimated. However, this did not permit an estimate of the cost of care in which alcohol abuse was a risk factor only. Based on the available data showing that between 3% and 10% of inpatients have a directly alcohol-related condition, estimates of in-patient treatment costs varied from US$ 1300 to 2100 million. Among adult out-patients, 20% present with a disorder in which alcohol is a factor or suffer from an alcohol-related illness, which corresponds to a cost of about US$ 1600 million. Thus, these methods yield minimum year's cost estimated between US$ 2500 and 3300 million. These costs are high, compared to the low level of financing for the specialized facilities offering treatment to people in difficulty due to alcohol excess, which was US$ 23 million in that year. As regards social and total costs, estimates from four Western countries have found that about 75% of the total costs of alcohol abuse was attributable to social harm, and 25% to medical costs. Applying this ratio to the French data gives an estimated total cost to French society of about US$ 13 200 million, i.e. 1.04% of the gross national product.
(1)基于归因于酒精滥用病例比例的估算(酒精滥用因素);(2)基于门诊和住院患者酒精滥用患病率的估算。对于普通人群中酒精滥用患病率为10%的情况,1996年的最低成本约为23亿美元;患病率为15%时,成本为27亿美元。该成本涉及与酒精滥用直接或间接相关的健康障碍。它未将酒精中毒导致的事故伤害计算在内,且低估了门诊护理成本。根据医院中与酒精相关疾病的患病率,可以估算出因酒精影响导致的住院和门诊总成本的一定比例。然而,这无法估算仅将酒精滥用作为风险因素的护理成本。根据现有数据显示,3%至10%的住院患者患有与酒精直接相关的疾病,住院治疗成本估算在13亿至21亿美元之间。在成年门诊患者中,20%患有与酒精相关的疾病或患有酒精相关疾病,这相当于约16亿美元的成本。因此,这些方法得出的最低年度成本估算在25亿至33亿美元之间。与为因酒精过量而陷入困境的人提供治疗的专业设施的低水平资金(当年为2300万美元)相比,这些成本很高。关于社会成本和总成本,四个西方国家的估算发现,酒精滥用总成本的约75%可归因于社会危害,25%归因于医疗成本。将该比例应用于法国数据,得出法国社会的估计总成本约为132亿美元,即国民生产总值的1.04%。